Lombardi: Expert Stock Market Commentary & Forecasts, Financial & Economic Analysis Since 1986
Stock Market Commentary & Forecasts, Financial & Economic Analysis

Welcome to Profit Confidential • Thursday, May 24, 2012

In about 60 days, this company could announce it has a cure for

Friday, December 16th, 2005
By George Leong, B.Comm. for Profit Confidential

In about 60 days, this company could announce it has a cure for multiple sclerosis, better known as MS. The big pharmaceutical companies may pay $80 for the stock, even $90. Here’s where you can buy it today for $2.85!

 I couldn’t believe my ears…

 Sitting at a bar with Rob, a former securities lawyer, I learned about how he had just made a huge investment in a company working on a cure for MS.

 While multiple sclerosis doesn’t get the press that other diseases do, it still affects a large portion of North Americans. One of my friends is afflicted with MS. Suffice it to say, I was more than a little interested.

 ”A cure for MS would be the biggest medical discovery since the polio vaccine!” he explained. And he was right. It would be a huge medical development. I had to know more…

 Rob proceeded to tell me that the company was recently approved to commence the third phase of its clinical tests. After that, the pharmaceutical companies could be beating down the doors!

 ”This stock could be worth $80 to $90 a share,” continued Rob. “That’s amazing, considering it’s trading at only $2.85 today.”

 Convinced, I got the name of the company and did my own research. Rob was right. This company was a profit time-bomb about to go off.

 Why?

 According to its filings, this biotech company had all the right things going for it:

 — The first two phases of the clinical trial were complete and the results were there in black and white.

 — The company had enlisted a top neurologist and expert in MS research as the lead investigator for the third phase of clinical trials.

 — The company had already received European and Canadian clearance to commence the third phase.

 In my opinion, this discovery is probably the greatest medical innovation humankind has seen in 50 years.

 How great?

 Imagine if you would have invested in the polio vaccine before the final phase of clinical testing was complete. Chances are you’d have made a fortune.

 And yet, this MS biotech is just sitting there, about to get to the point where Pfizer, Squibb, Bayer… chances are every pharmaceutical company… could be bidding on this amazing breakthrough.

 And where will you be when this stock starts to rise in price? If you listen to my advice based on solid investigation, then you could be enjoying the benefits your portfolio could reap, posting incredible profits.

Next Post:
Previous Post:

Tags: , ,










Sign Up for PROFIT CONFIDENTIAL and
receive a FREE copy of our exclusive report:
"A GOLDEN OPPORTUNITY FOR STOCK MARKET INVESTORS"

Enter e-mail:

We respect your privacy and
will never share your e-mail address.



Profit Confidential AuthorGeorge is a Senior Editor at Lombardi Financial, and has been involved in analyzing the stock markets for two decades where he employs both fundamental and technical analysis. His overall market timing and trading knowledge is extensive in the areas of small-cap research and option trading. George is the editor of several of Lombardi’s popular financial newsletters, including The China Letter, Special Situations, and Obscene Profits, among others. His trading advice on stocks and options is also found on his daily trading site, Daily Profits. He has written technical and fundamental columns for numerous stock market news web sites, and he is the author of Quick Wealth Options Strategy and Mastering 7 Proven Options Strategies. Prior to starting with Lombardi Financial, George was employed as a financial analyst with Globe Information Services.

Daily Profits


Enter your e-mail address to subscribe to
Profit Confidential — IT'S FREE!
Enter e-mail:
ALSO RECEIVE A FREE COPY of our exclusive report:
"A Golden Opportunity for Stock Market Investors"

McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams

 

Corporate
About Us
Privacy
Disclaimer
Contact Us
White List
Sitemap

Profit Confidential
Predictions
Gurus
Archives
FREE Sign-Up
RSS
Twitter
Facebook

Editors
Michael Lombardi
George Leong
Mitchell Clark
Tony Jasansky
Robert Appel
Wendy Potter
Sasha Cekerevac

Topics
Gold Stocks
Stock Market
Bear Market
Bull Market
US Dollar
Euro
Interest Rates

Expertise
U.S.Deficit
Real Estate Market
Debt Crisis
Chinese Economy
Economic Analysis

Guidance
Investment Guidance
Retirement Plan
Chinese Stocks
The Best Stocks
Gold Stock Picking
Real Estate Investment

Resources
Gold
Precious Metals
Real Estate News
Gold Investments
Investing in Real Estate


Profit Confidential Disclaimer